Arrowhead Pharmaceuticals
ARWR
#2136
Rank
โ‚น820.37 B
Marketcap
โ‚น5,858
Share price
8.76%
Change (1 day)
437.15%
Change (1 year)

Revenue for Arrowhead Pharmaceuticals (ARWR)

Revenue in 2025 (TTM): โ‚น95.25 Billion

According to Arrowhead Pharmaceuticals 's latest financial reports the company's current revenue (TTM ) is โ‚น101.93 Billion. an increase over the revenue in the year 2024 that were of โ‚น0.21 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Arrowhead Pharmaceuticals from 2000 to 2025

Annual revenue

Year Revenue Change
2025 โ‚น97.93 B45565.27%
2024 โ‚น0.21 B-98.58%
2023 โ‚น15.12 B-34.31%
2022 โ‚น23.03 B114.26%
2021 โ‚น10.74 B84.1%
2020 โ‚น5.83 B-49.95%
2019 โ‚น11.66 B252.8%
2018 โ‚น3.30 B69.51%
2017 โ‚น1.95 B540.77%
2016 โ‚น0.30 B1696.54%
2015 โ‚น16.94 M-11.46%
2014 โ‚น19.14 M77.04%
2013 โ‚น10.81 M-29.96%
2012 โ‚น15.43 M1118%
2011 โ‚น1.26 M-99.37%
2010 โ‚น0.20 B34.05%
2009 โ‚น0.14 B93.39%
2008 โ‚น77.24 M
2006 โ‚น15.68 M-51.17%
2005 โ‚น32.11 M
2002 โ‚น0.11 M-54.84%
2001 โ‚น0.26 M-77.46%
2000 โ‚น1.16 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Johnson & Johnson
JNJ
โ‚น8.801 T 8,533.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
โ‚น179.58 B 76.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚น25.04 B-75.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
โ‚น18.01 B-82.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น347.01 B 240.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
โ‚น17.03 M-99.98%๐Ÿ‡บ๐Ÿ‡ธ USA